VanEck Pharmaceutical ETF (PPH)
VanEck Pharmaceutical ETF operates in the Asset Management industry of the Financial Services sector, headquartered in New York, NY, US. The stock last traded at $111.43, down 0.53% on the session, giving a market capitalisation of $968.1M. Its beta of 0.41 implies it has historically moved less than the broad market.
VanEck Pharmaceutical ETF (PPH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.
VanEck Pharmaceutical ETF is most often compared with the following Financial Services names: